Thu Truong
Dermatology Residency · Montefiore Medical Center/Albert Einstein College of Medicine
Credentials: · ·
History
2024–2025- 2020–2024
- 2016–2020
Research
Deucravacitinib: The First FDA-Approved Oral TYK2 Inhibitor for Moderate to Severe Plaque Psoriasis
Review · Annals of Pharmacotherapy · 2024 · First of 5 authors · 36 citations
Artificial intelligence in dermatology: advancements and challenges in skin of color
Review · International Journal of Dermatology · 2024 · 32 citations
Review · Seizure · 2019 · 30 citations
24 papers
- GP
11 papers
- SR
7 papers · 7 as a resident
- SK
6 papers · 3 as a resident
- BS
3 papers
3 papers
- JM
3 papers
3 papers
